When the Pfizer-BioNTech COVID-19 vaccine was authorized for emergency use by the Food and Drug Administration (FDA) in December 2020, President Donald Trump referred to it as a "medical miracle." ...
The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger RNA, or mRNA, technology. The U.S. Department of Health and Human ...
The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...
In early 2020, when the first genetic sequence of the new coronavirus was posted online, scientists were ready. Within hours, they began designing a vaccine. Within weeks, clinical trials were ...
Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure Partnership strengthens global preparedness against a significant pandemic ...
Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure If licensed and in the event of an influenza pandemic, Moderna will allocate 20% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results